Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 28, 2015; 21(8): 2323-2335
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2323
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2323
Figure 3 Profilin-1 knockdown inhibits tumor growth.
A: Expression of profilin-1 (PFN1) was assessed in the PFN1-transfected cells, the untreated control and the negative control (NC)-transfectants by Western blot; B: Cell proliferation levels were measured using the cell counting kit-8 on 1, 2, 3, 4 and 5 d. The optical density (A) represents the proliferative characteristics of the treated cells; C: PFN1 silencing resulted in significantly lower colony-forming efficiency; D: Cell-cycle distribution was analyzed by flow cytometry on SGC-7901 cells. The results obtained from three independent experiments are shown. aP < 0.05, bP < 0.01 vs other groups. GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; Si: Silencing.
-
Citation: Cheng YJ, Zhu ZX, Zhou JS, Hu ZQ, Zhang JP, Cai QP, Wang LH. Silencing profilin-1 inhibits gastric cancer progression
via integrin β1/focal adhesion kinase pathway modulation. World J Gastroenterol 2015; 21(8): 2323-2335 - URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2323.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i8.2323